EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy

Yanmeng Wang, Niels Vandewalle, Kim De Veirman, Karin Vanderkerken, Eline Menu, Elke De Bruyne

Cell Communication and Signaling · 11.06.2024 · 22 (1)

DOI: 10.1186/s12964-024-01699-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Communication and Signaling, online erschienen am 11.06.2024. Verfasst von Yanmeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium. Hauptthemen laut MEDLINE: Multiple Myeloma, TOR Serine-Threonine Kinases, Signal Transduction. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Vrije Universiteit Brussel, Kom op tegen Kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Myeloma (MM), a cancer of terminally differentiated plasma cells, is the second most prevalent hematological malignancy and is incurable due to the inevitable development of drug resistance. Intense protein synthesis is a distinctive trait of MM cells, supporting the massive production of clonal immunoglobulins or free light chains. The mammalian target of rapamycin (mTOR) kinase is appreciated as a master regulator of vital cellular processes, including regulation of metabolism and protein synthesis, and can be found in two multiprotein complexes, mTORC1 and mTORC2. Dysregulation of these complexes is implicated in several types of cancer, including MM. Since mTOR has been shown to be aberrantly activated in a large portion of MM patients and to play a role in stimulating MM cell survival and resistance to several existing therapies, understanding the regulation and functions of the mTOR complexes is vital for the development of more effective therapeutic strategies. This review provides a general overview of the mTOR pathway, discussing key discoveries and recent insights related to the structure and regulation of mTOR complexes. Additionally, we highlight findings on the mechanisms by which mTOR is involved in protein synthesis and delve into mTOR-mediated processes occurring in MM. Finally, we summarize the progress and current challenges of drugs targeting mTOR complexes in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaTOR Serine-Threonine KinasesSignal TransductionHumansAnimalsMolecular Targeted TherapyMTOR InhibitorsMechanistic Target of Rapamycin Complex 2

Stichwörter der Autor:innen

Multiple myelomaProtein synthesisTargeted therapymTOR

Substanzen

TOR Serine-Threonine KinasesMTOR InhibitorsMechanistic Target of Rapamycin Complex 2MTOR protein, human

Autor:innen und Institutionen

  • Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium.
  • Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.
  • Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium. Eline.Menu@vub.be.
  • Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium. Elke.De.Bruyne@vub.be.

Förderung

  • China Scholarship Council
  • Vrije Universiteit Brussel
  • Kom op tegen Kanker
  • Fonds Wetenschappelijk Onderzoek
  • International Myeloma Foundation
  • Wetenschappelijk Fonds Willy Gepts, Universitair Ziekenhuis Brussel

Zitieren

APA

Wang, Y., Vandewalle, N., De Veirman, K., Vanderkerken, K., Menu, E., & De Bruyne, E. (2024). Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy. Cell Communication and Signaling, 22(1). https://doi.org/10.1186/s12964-024-01699-3

Vancouver

Wang Y, Vandewalle N, De Veirman K, Vanderkerken K, Menu E, De Bruyne E. Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy. Cell Communication and Signaling. 2024;22(1). doi:10.1186/s12964-024-01699-3

BibTeX
@article{Wang2024,
  author = {Wang, Yanmeng and Vandewalle, Niels and De Veirman, Kim and Vanderkerken, Karin and Menu, Eline and De Bruyne, Elke},
  title = {Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy},
  journal = {Cell Communication and Signaling},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12964-024-01699-3}
}
Kostenlos starten →